抗HLA I类IgG子类在输血折射性中歪曲了血小板激活机制
Adèle Couvidou1, Mathieu Wald2, Catherine Angénieux1
1Université de Strasbourg, INSERM, Etablissement Français du Sang (EFS) Grand Est, BPPS UMR_S 1255, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg.
Haematologica
|September 18, 2025
概括
由于抗HLA-I IgG抗体,血小板输血折射性 (PTR) 可能发生. 不同的IgG亚类通过不同的机制激活血小板,影响PTR发育和治疗选择.
科学领域:
- 免疫学 免疫学 免疫学
- 输血医学 输血医学
- 血液学 血液学 血液学
背景情况:
- 血小板输血折射性 (PTR) 是接受反复输血的患者的治疗失败.
- PTR的主要原因是受体IgG抗体对捐赠人白细胞抗原I类 (HLA-I) 分子.
- 抗HLA-I IgG存在与PTR之间的相关性不一致,这表明抗体特性至关重要.
研究的目的:
- 调查抗HLA-IIIgG亚类在血小板输血折射性中的作用.
- 阐明通过不同IgG子类介导的血小板激活的独特机制.
主要方法:
- 在有或没有PTR的患者中分析抗HLA-IIIgG子类.
- 使用人类仿真泛HLA-I IgG1,IgG2和IgG3抗体.
- 评估功能性血小板激活标志物:聚合,P-选择素暴露和Annexin V结合.
主要成果:
- 在PTR患者和非PTR患者之间,IgG子类的分布有所不同;非PTR患者中IgG1占主导地位,而在PTR患者中发现IgG1与IgG2或IgG3.
- 所有测试的IgG子类都诱导了血小板激活,但通过不同的途径.
- hIgG2诱导的激活依赖于CD32a,而hIgG1和hIgG3依赖于补充征集.
结论:
- 这些发现突出了PTR中不同抗HLA-IIgG子类的独特致病机制.
- 这项研究有助于优先考虑致病性抗体,并为耐火患者选择兼容的血小板组件.
相关概念视频
02:45Blood Transfusion and Agglutination
14.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
14.0K
01:10Blood Typing
2.4K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
2.4K
01:15Blood Transfusion
2.1K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.1K
01:40Cell-mediated Immune Responses
83.5K
Overview
83.5K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
01:19Rh Blood Group
2.8K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
2.8K